Combination therapy for pulmonary artery hypertension: What is the evidence?

Cardiology

Volumn 120, Issue 3, 2012, Pages 172-173

  Rubin, Lewis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTACYCLIN;

COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; ENZYME INHIBITION; EXERCISE; GENE OVEREXPRESSION; LUNG HEMODYNAMICS; MONOTHERAPY; NOTE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY;

EID: 84855765349     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000335709     Document Type: Note

References (1)

1. Bai Y, Sun L, Hu S, Wei Y: Combination therapy in pulmonary arterial hypertension: a meta-analysis. Cardiology 2011;120:157-165.